Six-minute walk distance predicts mortality in liver transplant candidates

Elizabeth J. Carey, D Eric Steidley, Bashar A. Aqel, Thomas J. Byrne, Kristin L. Mekeel, Jorge Rakela, Hugo E Vargas, David D. Douglas

Research output: Contribution to journalArticle

118 Citations (Scopus)

Abstract

The 6-minute walk distance (6MWD) is a simple test measuring global physical function. It is commonly used to predict mortality in patients with cardiac and pulmonary diseases, but it is also useful in assessing the functional status of patients with a variety of other medical conditions. We sought to determine (1) the characteristics of the 6MWD in patients listed for liver transplantation (LT), (2) the existence of a relationship between the 6MWD and the quality of life, and (3) the relationship between the 6MWD and survival in LT candidates. The 6MWD was prospectively measured in all patients listed for LT. The 6MWD was determined when the listed Model for End-Stage Liver Disease (MELD) score was ≥15. Patients were followed until LT, death, removal from the wait list, or the end of the study period. Quality of life was assessed with the Short Form 36 (SF-36). In 121 patients, the mean 6MWD was 369 ± 122 m; it was not related to age, height, weight, body mass index, albumin level, or etiology of liver disease and showed a moderate correlation with the physical component score (PCS) on the SF-36 (r = 0.4) and a moderate inverse correlation with the native MELD score (r = -0.61). In an unadjusted analysis, a high native MELD score, a low 6MWD, and a low PCS were associated with mortality, with only the 6MWD retaining significance after adjustment for covariates. Each 100-m increase in the 6MWD was significantly associated with increased survival (hazard ratio = 0.48, P = 0.0001), with 6MWD < 250 m being associated with an increased risk of death (P = 0.0001). In conclusion, the 6MWD is significantly reduced in patients awaiting LT and is inversely correlated with the native MELD score. A pretransplant 6MWD < 250 m is a risk for death on the wait list.

Original languageEnglish (US)
Pages (from-to)1373-1378
Number of pages6
JournalLiver Transplantation
Volume16
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

End Stage Liver Disease
Liver Transplantation
Transplants
Mortality
Liver
Quality of Life
Survival
Lung Diseases
Liver Diseases
Albumins
Heart Diseases
Body Mass Index
Weights and Measures

ASJC Scopus subject areas

  • Surgery
  • Transplantation
  • Hepatology

Cite this

Carey, E. J., Steidley, D. E., Aqel, B. A., Byrne, T. J., Mekeel, K. L., Rakela, J., ... Douglas, D. D. (2010). Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplantation, 16(12), 1373-1378. https://doi.org/10.1002/lt.22167

Six-minute walk distance predicts mortality in liver transplant candidates. / Carey, Elizabeth J.; Steidley, D Eric; Aqel, Bashar A.; Byrne, Thomas J.; Mekeel, Kristin L.; Rakela, Jorge; Vargas, Hugo E; Douglas, David D.

In: Liver Transplantation, Vol. 16, No. 12, 12.2010, p. 1373-1378.

Research output: Contribution to journalArticle

Carey, Elizabeth J. ; Steidley, D Eric ; Aqel, Bashar A. ; Byrne, Thomas J. ; Mekeel, Kristin L. ; Rakela, Jorge ; Vargas, Hugo E ; Douglas, David D. / Six-minute walk distance predicts mortality in liver transplant candidates. In: Liver Transplantation. 2010 ; Vol. 16, No. 12. pp. 1373-1378.
@article{9694916fd0204838813bc3a861b8fc02,
title = "Six-minute walk distance predicts mortality in liver transplant candidates",
abstract = "The 6-minute walk distance (6MWD) is a simple test measuring global physical function. It is commonly used to predict mortality in patients with cardiac and pulmonary diseases, but it is also useful in assessing the functional status of patients with a variety of other medical conditions. We sought to determine (1) the characteristics of the 6MWD in patients listed for liver transplantation (LT), (2) the existence of a relationship between the 6MWD and the quality of life, and (3) the relationship between the 6MWD and survival in LT candidates. The 6MWD was prospectively measured in all patients listed for LT. The 6MWD was determined when the listed Model for End-Stage Liver Disease (MELD) score was ≥15. Patients were followed until LT, death, removal from the wait list, or the end of the study period. Quality of life was assessed with the Short Form 36 (SF-36). In 121 patients, the mean 6MWD was 369 ± 122 m; it was not related to age, height, weight, body mass index, albumin level, or etiology of liver disease and showed a moderate correlation with the physical component score (PCS) on the SF-36 (r = 0.4) and a moderate inverse correlation with the native MELD score (r = -0.61). In an unadjusted analysis, a high native MELD score, a low 6MWD, and a low PCS were associated with mortality, with only the 6MWD retaining significance after adjustment for covariates. Each 100-m increase in the 6MWD was significantly associated with increased survival (hazard ratio = 0.48, P = 0.0001), with 6MWD < 250 m being associated with an increased risk of death (P = 0.0001). In conclusion, the 6MWD is significantly reduced in patients awaiting LT and is inversely correlated with the native MELD score. A pretransplant 6MWD < 250 m is a risk for death on the wait list.",
author = "Carey, {Elizabeth J.} and Steidley, {D Eric} and Aqel, {Bashar A.} and Byrne, {Thomas J.} and Mekeel, {Kristin L.} and Jorge Rakela and Vargas, {Hugo E} and Douglas, {David D.}",
year = "2010",
month = "12",
doi = "10.1002/lt.22167",
language = "English (US)",
volume = "16",
pages = "1373--1378",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "12",

}

TY - JOUR

T1 - Six-minute walk distance predicts mortality in liver transplant candidates

AU - Carey, Elizabeth J.

AU - Steidley, D Eric

AU - Aqel, Bashar A.

AU - Byrne, Thomas J.

AU - Mekeel, Kristin L.

AU - Rakela, Jorge

AU - Vargas, Hugo E

AU - Douglas, David D.

PY - 2010/12

Y1 - 2010/12

N2 - The 6-minute walk distance (6MWD) is a simple test measuring global physical function. It is commonly used to predict mortality in patients with cardiac and pulmonary diseases, but it is also useful in assessing the functional status of patients with a variety of other medical conditions. We sought to determine (1) the characteristics of the 6MWD in patients listed for liver transplantation (LT), (2) the existence of a relationship between the 6MWD and the quality of life, and (3) the relationship between the 6MWD and survival in LT candidates. The 6MWD was prospectively measured in all patients listed for LT. The 6MWD was determined when the listed Model for End-Stage Liver Disease (MELD) score was ≥15. Patients were followed until LT, death, removal from the wait list, or the end of the study period. Quality of life was assessed with the Short Form 36 (SF-36). In 121 patients, the mean 6MWD was 369 ± 122 m; it was not related to age, height, weight, body mass index, albumin level, or etiology of liver disease and showed a moderate correlation with the physical component score (PCS) on the SF-36 (r = 0.4) and a moderate inverse correlation with the native MELD score (r = -0.61). In an unadjusted analysis, a high native MELD score, a low 6MWD, and a low PCS were associated with mortality, with only the 6MWD retaining significance after adjustment for covariates. Each 100-m increase in the 6MWD was significantly associated with increased survival (hazard ratio = 0.48, P = 0.0001), with 6MWD < 250 m being associated with an increased risk of death (P = 0.0001). In conclusion, the 6MWD is significantly reduced in patients awaiting LT and is inversely correlated with the native MELD score. A pretransplant 6MWD < 250 m is a risk for death on the wait list.

AB - The 6-minute walk distance (6MWD) is a simple test measuring global physical function. It is commonly used to predict mortality in patients with cardiac and pulmonary diseases, but it is also useful in assessing the functional status of patients with a variety of other medical conditions. We sought to determine (1) the characteristics of the 6MWD in patients listed for liver transplantation (LT), (2) the existence of a relationship between the 6MWD and the quality of life, and (3) the relationship between the 6MWD and survival in LT candidates. The 6MWD was prospectively measured in all patients listed for LT. The 6MWD was determined when the listed Model for End-Stage Liver Disease (MELD) score was ≥15. Patients were followed until LT, death, removal from the wait list, or the end of the study period. Quality of life was assessed with the Short Form 36 (SF-36). In 121 patients, the mean 6MWD was 369 ± 122 m; it was not related to age, height, weight, body mass index, albumin level, or etiology of liver disease and showed a moderate correlation with the physical component score (PCS) on the SF-36 (r = 0.4) and a moderate inverse correlation with the native MELD score (r = -0.61). In an unadjusted analysis, a high native MELD score, a low 6MWD, and a low PCS were associated with mortality, with only the 6MWD retaining significance after adjustment for covariates. Each 100-m increase in the 6MWD was significantly associated with increased survival (hazard ratio = 0.48, P = 0.0001), with 6MWD < 250 m being associated with an increased risk of death (P = 0.0001). In conclusion, the 6MWD is significantly reduced in patients awaiting LT and is inversely correlated with the native MELD score. A pretransplant 6MWD < 250 m is a risk for death on the wait list.

UR - http://www.scopus.com/inward/record.url?scp=78649817483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649817483&partnerID=8YFLogxK

U2 - 10.1002/lt.22167

DO - 10.1002/lt.22167

M3 - Article

C2 - 21117246

AN - SCOPUS:78649817483

VL - 16

SP - 1373

EP - 1378

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 12

ER -